Yaşlılık Döneminde Koruyucu Sağlık Bakımı

Öz

Hastalıkların önlenmesi ve sağlığın geliştirilmesi, genç erişkinlerde olduğu gibi yaşlılık döneminde de önemli bir sağlık hizmetidir. Bilindiği gibi, yaş arttıkça kronik hastalık oranı artmaktadır. Yaşlıların %80’ninde en az 1 ek hastalık, %50’sinde ise en az 2 ek hastalık vardır. Yaşlılarda, kronik sağlık sorunlarının yüksek prevalansı göz önüne alınmalıdır. Ayrıca kanıta dayalı müdahaleler ile problemler oluşmadan, yaşam kalitesini maksimum artırmaya çalışmak önemlidir. Unutulmamalıdır ki, fonksiyonelliğin kaybı ve bağımlılık yaşlanmanın kaçınılmaz bir sonucu değildir. Yaşlıların tümü için sağlığın geliştirilmesinden bahsetmek mümkündür.

Kaynakça

1. Centers for Disease Control and Prevention and The Merck Company Foundation. The State of Aging and Health in America 2007. The Merck Company Foundation, Whitehouse Station, NJ 2007. Available at: http://www.cdc.gov (10 Nisan 2015’te erişilmiştir).
2. Cigolle CT, Langa KM, Kabeto MU, et al. Geriatric conditions and disability: the Health and Retirement Study. Ann Intern Med 2007; 147:156.
3. Aile Hekimliği 1. Aşama Uyum Eğitimi, Birinci Basamak Sağlık Hizmetleri Başkan Yardımcılığı, Aile Hekimliği Eğitim Geliştirme Daire Bşklığı, 2013.
4. Reuben DB. Medical care for the final years of life: "When you're 83, it's not going to be 20 years". JAMA 2009; 302:2686.
5. Artaud F, Dugravot A, Sabia S, ark. Unhealthy behaviours and disability in older adults: three-City Dijoncohortstudy. BMJ 2013; 347:f4240.
6. Karan MA. Yaşlı Hastanın Değerlendirilmesi. Klinik Gelişim 2004; 17 (2): 1-8
7. US Department of Healthand Human Services. Healthy People 2010, conference edition. Washington DC: U.S. Department of Healthand Human Services; 2000. Available at: www.healthypeople.gov (21 Mayıs 2015’te erişilmiştir)
8. King AC, Guralnik JM. Maximizing the potential of an aging population. JAMA 2010; 304:1944.

9. Nelson ME, Rejeski WJ, Blair SN, ark. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116:1094.
10. Province MA, Hadley EC, Hornbrook MC, ark. Theeffects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of InterventionTechniques. JAMA 1995; 273:1341.
11. Wolf SL, Barnhart HX, Kutner NG, ark. Reducing frailty and falls in older persons: an investigation of TaiChi and computerized balance training. Atlanta FICSIT Group. Frailty and Injuries: CooperativeStudies of Intervention Techniques. J Am GeriatrSoc 1996; 44: 489.
12. Nelson ME, Rejeski WJ, Blair SN, ark. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1094.
13. Doolan DM, Froelicher ES. Efficacy of smoking cessation intervention among special populations: review of the literature from 2000 to 2005. Nurs Res 2006; 55: 29.
14. Burns DM. Cigarette smoking among the elderly: disease consequences and the benefits of cessation. Am J HealthPromot 2000; 14:357.
15. Gnanadesigan N, Fung CH. Quality indicators for screening and prevention in vulnerable elders. J Am GeriatrSoc 2007; 55: 417.
16. Elhassan A, Chow RD. Smoking cessation in the elderly. Clin Geriatr 2007; 15: 38.
17. Clinical guidelines for alcohol use disorders in older adults. American Geriatrics Society (AGS) Position Statement. American Geriatrics Society, New York 2003.
18. Gnanadesigan N, Fung CH. Quality indicators for screening and prevention in vulnerable elders. J Am GeriatrSoc 2007; 55 Suppl 2:S417.
19. Clinical guidelines for alcohol use disorders in older adults. American Geriatrics Society (AGS) Position Statement. American Geriatrics Society, New York 2003.
20. Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication. USPSTF. Release Date: March 2009. http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication (06 Kasım 2014’te erişilmiştir
21. Ridker PM, Cook NR, Lee IM, ark. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352:1293
22. Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am GeriatrSoc 2007; 55 Suppl 2:S373.
23. Nelson MR, Liew D, Bertram M, Vos T. Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged>or =70. BMJ 2005; 330:1306.
24. Bhatt DL, Scheiman J, Abraham NS, ark. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008; 118:1894.
25. Baştürk B, Boyacıoğlu S. İmmün yaşlanma. Türk. Geriatri Dergisi 2004;7:159-61.
26. Wong K, Campitelli MA, Stukel TA, ark.Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. ArchInternMed. 2012;172(6):484.
27. Tan AA. Inflamation in elderly. Türk Geriatri Derg 2009;12-96.
28. Weston WM, Friedland LR, Wu X, ark. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials. Vaccine. 2012;30:1721-8.
29. Blasi F, FM. Mantero, Pier Achille Santus, ark. Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect. 2012;18(Suppl 5):7-14.
30. Smith KJ, Wateska AR, Nowalk MP, ark. Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults. Am J PrevMed. 2013;44:373–81.
31. Tomczyk S, Bennett NM, Stoecker C, ark. Use of 13-valent pneumococcal conjugate vaccineand 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2014; 63:822.
32. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007; 356:1338.
33. Oxman MN, Levin MJ, Johnson GR, ark. A vaccine to prevent herpes zoster and post herpetic neuralgia in older adults. N Engl J Med 2005; 352:2271.
34. Tseng HF, Smith N, Harpaz R, ark. Herpes zoster vaccine in older adults and the risk of subsequentt herpes zoster disease. JAMA 2011; 305:160.
35. Siegel R, Ward E, Brawley O, ark. Cancerstatistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212.
36. Kimbro LB, Mangione CM, Steers WN, ark. Depression and all-cause mortality in persons with diabetes mellitus: are older adults at higher risk? Results from the Translating Research Into Action for Diabetes Study. J Am GeriatrSoc 2014; 62:1017–1022
37. Beckett N, Peters R, TuomilehtoJ,ark. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomized controlled trial. BMJ 2012; 344:7541.
38. Lansdorp-Vogelaar I, Gulati R, Mariotto AB, ark. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 2014; 161:104.
39. Yaman H, Akdeniz M, "Yaşlı Dostu Birinci Basamak Sağlık Hizmetleri Uygulamaları: DSÖ,Yaşlı Dostu Birincil Bakım Enstrumanı", Sürekli Tıp Eğitimi Dergisi 2008;17: 11-13.
40. Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: A summary of the evidence for the U.S. Preventive Services. Ann Intern Med 2002; 136: 765-76..
41. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2015;38: 1-94
42. Mursu J, Robien K, Harnack LJ, ark. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med 2011; 171:1625.
43. Fung CH, Spencer B, Eslami M, ark. Quality indicators for the screening and care of urinary incontinence in vulnerable elders. J Am GeriatrSoc 2007; 55: 443.